Author:
Xiang Lilin,Zhang Lin,Zhang Tong,Zhang Hanyu,Guo Cihang,Liu Shi,Wang Qiongxin,Cai Huanhuan,Lu Zhibing
Abstract
After its initial outbreak in 2019, the 2019 novel coronavirus disease (COVID-19) remains a global health concern. COVID-19 is well known for causing severe respiratory pathology, but it can also cause a variety of extra-pulmonary manifestations. Among them, myocardial injury has received substantial attention because it is usually associated with poor prognosis and mortality, thus emphasizing the importance of monitoring and managing myocardial injury in patients with COVID-19. Myocarditis has received attention as a complication of myocardial injury during and after the onset of COVID-19. Here, to aid in clinical decision-making, we present a narrative review on COVID-19- associated myocardial injury and myocarditis, discussing clinical evidence, pathogenesis, diagnostic tools, and therapeutic strategies.
Reference112 articles.
1. COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention;A Sharma;Viruses,2021
2. The economic and long-term health consequences of canadian COVID-19 lockdowns;KA Bryan;Can Public Policy,2021
3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;C Huang;Lancet,2020
4. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance;T Kotecha;Eur Heart J,2021
5. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China;Q Ruan;Intensive Care Med,2020